- increased bone mineral density / IMPC
- decreased circulating HDL cholesterol level / IMPC
- increased circulating calcium level / IMPC
- increased circulating phosphate level / IMPC
- increased heart weight / IMPC
- decreased erythrocyte cell number / IMPC
- increased lean body mass / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating serum albumin level / IMPC
- increased circulating glucose level / IMPC
- increased circulating sodium level / IMPC
- preweaning lethality, complete penetrance / IMPC
- hypertrophy / IMPC
C57BL/6NTac-Ndufs3tm1a(EUCOMM)Wtsi/IcsOrl
Status | Available to order |
EMMA ID | EM:07730 |
International strain name | C57BL/6NTac-Ndufs3tm1a(EUCOMM)Wtsi/IcsOrl |
Alternative name | EPD0057_2_A08 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Ndufs3tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Ndufs3 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | ICS, Institut Clinique de la Souris |
Provider affiliation | ICS, Institut Clinique de la Souris |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0057_2_A08. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | heterozygous C57BL/6NTac, wild-type C57BL/6NTac |
Stage of embryos | 8-cell |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Leigh syndrome with leukodystrophy / Orphanet_255241
- Isolated complex I deficiency / Orphanet_2609
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased circulating calcium level / IMPC
- increased heart weight / IMPC
- increased bone mineral density / IMPC
- preweaning lethality, complete penetrance / IMPC
- increased circulating phosphate level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating cholesterol level / IMPC
- hypertrophy / IMPC
- increased lean body mass / IMPC
- increased circulating sodium level / IMPC
- decreased erythrocyte cell number / IMPC
- decreased circulating serum albumin level / IMPC
- increased circulating glucose level / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).